Green light for clinical trial of new tuberculosis vaccine candidate
European scientists are one step closer to delivering a new, safe and more effective vaccine against tuberculosis developed through EU research funding. Swiss-medic, the Swiss regulatory authority for medicine, has given permission to start assessing the new TB vaccine in healthy adult volunteers, paving the way for trials to start. The vaccine, MTBVAC, will be the first of its kind to start clinical evaluation.
> Read more